TP-0903
TP 0903 is a drug used to treat Advanced Solid Tumors, BRAF-Mutated Melanoma, CLL, and other conditions. TP 0903 is being actively studied in 1 study; no studies for this drug have been completed so far.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Sumitomo Pharma Oncology, Inc. | Mayo Clinic Arizona | |
| Mayo Clinic Florida | ||
| Mayo Clinic Rochester |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Terminated
- Chronic Lymphocytic Leukemia
- +3 more
- TP-0903
- TP-0903 and ibrutinib combination therapy
- Phoenix, Arizona
- +5 more
2022-04-04
Apr 4, 2022S
Active, not recruiting
- Advanced Solid Tumors
- +4 more
- TP-0903
- Phoenix, Arizona
- +15 more
2022-04-04
Apr 4, 2022